D. Viza

发表

Diffuse bands in the visible absorption spectra of dense alkali vapours

G. Pichler, S. Milošević, D. Viza, 1983 .

Transfer Factor in Virus-Associated Malignancies: An Underestimated Weapon in Prevention and Treatment of Cancer

P. Levine, D. Viza, G. Pizza, 2011 .

Cell mediated immunity to meet the avian influenza A ( H 5 N 1 ) challenge

D. Viza, D. Ablashi, M. Amadori, 2015 .

Cell mediated immunity to meet the avian influenza A (H5N1) challenge.

D. Viza, D. Ablashi, M. Amadori, 2006, Medical hypotheses.

Solubilization and Partial Purification of Human Leukaemic Specific Antigens

D. Viza, D. Davies, R. Harris, 1970, Nature.

HL-A, LEUKÆMIA, AND LEUKÆMIAASSOCIATED ANTIGENS

D. Viza, R. Harris, 1971 .

In vitro studies during long term oral administration of specific transfer factor

O. Baricordi, D. Viza, G. Pizza, 1996, Biotherapy.

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma.

R. Kyle, D. Bourboulia, M. Rettig, 2000, Blood.

Efficacy of transfer factor in treating patients with recurrent ocular herpes infections

E. Campos, D. Viza, L. Scorolli, 1996, Biotherapy.

Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and Zidovudine (ZDV)

D. Viza, F. Gritti, L. Guerra, 1996, Biotherapy.

Soluble extracts from a lymphoblastoid cell line modulate simian immunodeficiency syndrome (SAIDS) evolution.

D. Viza, S. Salahuddin, D. Ablashi, 1988, Journal of virological methods.

Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: A pilot study

P. Levine, U. Prasad, M. A. Jalaludin, 1996, Biotherapy.

Transfer Factor as an Option for Managing the COVID-19 Pandemic.

G. Brandi, D. Viza, D. Ablashi, 2020, Folia biologica.

AIDS and transfer factor: Myths, certainties and realities

D. Viza, 1996, Biotherapy.

Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.

D. Viza, H. Fudenberg, D. Ablashi, 2013, Folia biologica.

Transfer factor prevents relapses in herpes keratitis patients: A pilot study

D. Viza, L. Scorolli, G. Pizza, 1994, Biotherapy.

Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses

D. Viza, R. Baricordi, G. Pizza, 1996, Biotherapy.

Identification of an antigen associated with malignant melanoma

D. Viza, J. Phillips, 1975, International journal of cancer.

Orally administered specific transfer factor for the treatment of herpes infections.

D. Viza, J. Vich, J. Phillips, 1985, Lymphokine research.

SPECIFIC BOVINE TRANSFER FACTOR FOR THE TREATMENT OF HERPES INFECTIONS

D. Viza, J. Denis, J. Phillips, 1983 .

Antimelanoma hybridoma antibodies against partially purified melanoma antigen.

M. Daveau, T. Phillips, D. Viza, 1983, European journal of cancer & clinical oncology.

Solubilization of an antigen associated with certain bronchial tumours.

C. Boucheix, D. Viza, R. Guerin, 1975, European journal of cancer.

Detection of Human Leukaemia Associated Antigens in Leukaemic Serum and Normal Embryos

D. Viza, R. Jennison, R. Harris, 1971, Nature.

Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): A preliminary report

D. Viza, M. Masi, G. Pizza, 1996, Biotherapy.

Transfer factor for the treatment of chronic active hepatitis.

L. Barbara, A. Roda, D. Viza, 1979, The New England journal of medicine.

HUMAN TRANSPLANTATION ANTIGENS: THE HL‐A (Hu‐1) SYSTEM AND ITS HOMOLOGY WITH THE MOUSE H‐2 SYSTEM

J. Dausset, D. Viza, D. Davies, 1968, Transplantation.

Leukemia antigens.

D. Viza, R. Harris, O. Bernard-Degani, 1969, The Lancet.

Lymphocyte Stimulation in Pigs: Evidence for the Existence of a Single Major Histocompatibility Locus, PL-A

R. Binns, D. Viza, J. R. SUGAR, 1970, Nature.

A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer

D. Viza, P. Zucchelli, G. Pizza, 1996, Biotherapy.

Human HL-A transplantation antigens: separation of molecules carrying different immunological specificities determined by a single genotype.

J. Dausset, D. Viza, D. Davies, 1968, Biochemical and biophysical research communications.

Chemical inactivation of human immunodeficiency virus in vitro.

R. Busnel, A. Aranda-Anzaldo, D. Viza, 1992, Journal of virological methods.

Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports

P. Levine, D. Viza, D. Ablashi, 1996, Biotherapy.

Preliminary observations using HIV-specific transfer factor in AIDS

F. Chiodo, D. Viza, H. Fudenberg, 1996, Biotherapy.

Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma.

R. Biggar, P. Levine, D. Viza, 1990, Anticancer research.

Study of the lymphocyte fractions in the mixed lymphocyte culture in vitro

D. Viza, 1967, Experientia.

Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot study.

D. Viza, T. Bergami, L. Busutti, 1988, Lymphokine research.

HHV-6 inhibition by two polar compounds.

A. Aranda-Anzaldo, D. Viza, D. Ablashi, 1992, Antiviral research.

Dimethyl sulfoxide inhibits human immunodeficiency virus production in vitro.

A. Aranda-Anzaldo, D. Viza, J. Vich, 1991, Intervirology.

Chemical inducers of cell differentiation inhibit HIV in vitro

S. Salahuddin, A. Aranda-Anzaldo, D. Viza, 1989 .

[Determination, isolation and partial purification of leukemic antigens in humans].

D. Viza, D. Davies, R. Harris, 1970, La Presse medicale.

Too much hype

D. Viza, 1985, Nature.

Specific transfer factor protects mice against lethal challenge with herpes simplex virus.

D. Viza, D. Davies, J. Vich, 1986, Cellular immunology.

Spontaneous Production of High Levels of Leukocyte (α) Interferon by a Human Lymphoblastoid B-Cell Line (LDV/7)

P. Levine, S. Baron, D. Viza, 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.

D. Viza, M. Fini, G. Pizza, 1980, European urology.

SEPARATION OF HL-A TRANSPLANTATION ANTIGEN SPECIFICITIES

J. Dausset, D. Viza, D. Davies, 1970, Transplantation.

Transfer Factor for the Treatment of HBsAg-Positive Chronic Active Hepatitis

L. Barbara, D. Viza, E. Roda, 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Founding Editor Editor-in-chief Regional Editors Editorial Board Springer International Contents Abe, Sa: Meiosis of Primary Spermatocytes and Early Sper- Miogenesis in the Resultant Spermatids in Newt, Cynops Pyrrhogaster in Vitro 65 Heterogeneity of Inter- Mediate Filament Expression in Vascular S

Heidelberg, Geneva, Naples, 2022 .

Effect of in vitro produced transfer factor on the immune response of cancer patients.

C. Boucheix, D. Viza, G. Pizza, 1977, European journal of cancer.

In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder.

C. Boucheix, D. Viza, G. Pizza, 1976, British Journal of Cancer.

Immunotherapeutic approaches for renal cancer.

D. Viza, G. Pizza, C. de Vinci, 2002, Folia biologica.

Human lymphoblastoid cells in culture replicate immune information carried by xenogeneic RNA.

C. Boucheix, D. Viza, D. Kern, 1978, Differentiation; research in biological diversity.

Transfer factor in prevention of Burkitt's lymphoma relapses.

P. Levine, D. Viza, F. Nkrumah, 1987, Journal of experimental pathology.

Interleukin-2 treatment of lung metastases of a mammary adenocarcinoma. A case report.

D. Viza, G. Pizza, C. de Vinci, 1987, Journal of experimental pathology.

Chronic HTLV-III Infection in EBV-Genome Containing B-Cell Lines

D. Viza, S. Salahuddin, D. Ablashi, 1987 .

Human immunodeficiency virus type 1 productive infection in staurosporine‐blocked quiescent cells

A. Aranda-Anzaldo, D. Viza, 1992, FEBS letters.

Lymphocyte Stimulation by Soluble Human HL-A Transplantation Antigens

J. Dausset, D. Viza, D. Davies, 1968, Nature.

Lessons from a pilot study of transfer factor in chronic fatigue syndrome

P. Levine, D. Viza, H. Fudenberg, 1996, Biotherapy.

[Treatment of herpes infections with transfer factor].

D. Viza, O. Binet, J. Vich, 1984, Presse medicale.

Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man.

D. Viza, D. Davies, J. Vich, 1987, Journal of experimental pathology.

Experimental and Clinical Preliminary Study of Immunomodulators in the Treatment of Ocular Herpes

T. Hoang‐Xuan, D. Viza, J. Denis, 1985 .